Fred M. Powell

Insider Reports History

Location
C/O Bejing Med Pharm Corporation, 600 W. Germantown Pike, Suite 400, Plymouth Meeting, PA
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred M. Powell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LAVA Therapeutics NV Chief Financial Officer Share Options (Right to Buy) 125K Feb 13, 2025 Direct
LAVA Therapeutics NV Chief Financial Officer Common Shares 65K Jan 1, 2025 Direct
ANTARES PHARMA, INC. Executive Vice President & CFO Common Stock 0 $5.60 May 24, 2022 Direct
ANTARES PHARMA, INC. Executive Vice President & CFO Stock Option (right to buy) 0 May 24, 2022 Direct

Insider Reports Filed by Fred M. Powell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LVTX LAVA Therapeutics NV Feb 13, 2025 1 $0 4 Feb 18, 2025 Chief Financial Officer
LVTX LAVA Therapeutics NV Jan 1, 2025 0 $0 3 Jan 2, 2025 Chief Financial Officer
ATRS ANTARES PHARMA, INC. May 24, 2022 9 -$5.13M 4 May 26, 2022 Executive Vice President & CFO
ATRS ANTARES PHARMA, INC. Mar 3, 2022 2 -$43.7K 4 Mar 4, 2022 Executive Vice President & CFO
ATRS ANTARES PHARMA, INC. Feb 16, 2022 2 -$42.1K 4 Feb 18, 2022 Executive Vice President & CFO
ATRS ANTARES PHARMA, INC. Jun 10, 2021 4 $250K 4 Jun 14, 2021 Executive Vice President & CFO
ATRS ANTARES PHARMA, INC. Jun 8, 2021 1 -$52.9K 4 Jun 10, 2021 Executive Vice President & CFO